RMS Korea under fire over forcible stake acquisition of small shareholders

Published: 2012-07-06 06:59:00

Updated: 2012-07-06 06:59:00

RMS Korea, a drug wholesaler firm owned by the Netherlands’ Nethor Investment B.V., has been criticized for its forcible attempts to buy stakes of three small shareholders at cheaper price.

According to a law-firm representative Park Chong-hoon, Park Joon bum, executive managing director and l...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK